Key terms
About MDWD
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MDWD news
Yesterday
1:30pm ET
Analysts Are Bullish on Top Healthcare Stocks: Mediwound (MDWD), Ironwood Pharma (IRWD)
Mar 22
6:42am ET
Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD), Medtronic (MDT) and Eledon Pharmaceuticals (ELDN)
Mar 22
6:30am ET
Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Medtronic (MDT) and Mediwound (MDWD)
Mar 21
6:55pm ET
Mediwound Poised for Growth: A Strong Buy Recommendation Amidst Promising Prospects and Strategic Expansion
Mar 21
7:57am ET
MediWound Boasts Robust 2023 Financials and Growth
Mar 21
7:09am ET
MediWound reports Q4 EPS (19c), consensus (23c)
Mar 13
11:33am ET
MediWound management to meet virtually with Maxim
Feb 13
6:20am ET
Analysts Are Bullish on Top Healthcare Stocks: Immunovant (IMVT), 4D Molecular Therapeutics (FDMT)
Feb 12
7:04am ET
MediWound announces results from comparison of EscharEx vs SANTYL
Jan 12
1:35pm ET
Mediwound Poised for Growth: Buy Rating Affirmed Amidst FDA Progress, Revenue Forecasts, and Expansion Potential
Jan 12
11:36am ET
Biotech Alert: Searches spiking for these stocks today
Jan 09
7:03am ET
MediWound announces FDA accepted review the sBLA for NexoBrid
No recent news articles are available for MDWD
No recent press releases are available for MDWD
MDWD Financials
Key terms
Ad Feedback
MDWD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MDWD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range